Skip to main navigation Skip to search Skip to main content

Breast Cancer Outcomes in Intersex Individuals in the National Cancer Database

Kelley Chan, Lauren Cohen, Joseph Cotler, Elizabeth Carthcart-Rake, Adeline Berry, Alison May Berner, Chandler S. Cortina

Research output: Contribution to journalArticlepeer-review

Abstract

Up to 2% of the population is intersex, defined as individuals whose reproductive and/or sexual anatomy does not align with the historical definitions of male and female.1 Intersex characteristics often originate from chromosomal and inherited genetic variants (e.g., Klinefelter syndrome and Turner syndrome).1 Some may receive hormone replacement therapy,2,3,4 and while there are disparate outcomes in transgender/nonbinary/gender-diverse (TGD) patients with breast cancer,5 there are no cohorts examining intersex individuals. We aimed to explore patient demographics, tumor clinicopathologic features, treatment, and overall survival (OS) among patients with breast cancer and intersex characteristics in the National Cancer Database (NCDB).
Original languageEnglish
Number of pages5
JournalAnnals of Surgical Oncology
Early online date20 Jun 2026
DOIs
Publication statusE-pub ahead of print - 20 Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 5 - Gender Equality
    SDG 5 Gender Equality
  3. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities
  4. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions
  5. SDG 17 - Partnerships for the Goals
    SDG 17 Partnerships for the Goals

Fingerprint

Dive into the research topics of 'Breast Cancer Outcomes in Intersex Individuals in the National Cancer Database'. Together they form a unique fingerprint.

Cite this